Erlotinib-Associated Rash in Advanced Non-Small Cell Lung Cancer: Relation to Clinicopathological Characteristics, Treatment Response, and Survival

Systematic treatment of advanced non-small cell lung cancer (NSCLC) includes targeted treatment with epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs). The development of skin rash and its intensity have been associated with EGFR TKI’s efficacy. The main purpose of this study...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncol Res
Main Authors: Kainis, Ilias, Syrigos, Nikolaos, Kopitopoulou, Alexandra, Gkiozos, Ioannis, Filiou, Effrosyni, Nikolaou, Vasiliki, Papadavid, Evangelia
Formato: Artigo
Idioma:Inglês
Publicado em: Cognizant Communication Corporation 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7844560/
https://ncbi.nlm.nih.gov/pubmed/28390118
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3727/096504017X14913452320194
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados